End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTO

BACKGROUND: The absence of breast cancer cells in surgical specimens, i.e., pathological complete response (pCR), is widely recognized as a favorable prognostic factor after neoadjuvant therapy. In contrast, the presence of disease at surgery characterizes a prognostically heterogeneous group of pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Cosimo, Serena, Ciniselli, Chiara M., Pizzamiglio, Sara, Cappelletti, Vera, Silvestri, Marco, El-Abed, Sarra, Izquierdo, Miguel, Bajji, Mohammed, Nuciforo, Paolo, Huober, Jens, Cameron, David, Chia, Stephen, Gomez, Henry L., Iorio, Marilena V., Vingiani, Andrea, Pruneri, Giancarlo, Verderio, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927225/
https://www.ncbi.nlm.nih.gov/pubmed/36798690
http://dx.doi.org/10.3389/fonc.2022.1028825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927225/
https://www.ncbi.nlm.nih.gov/pubmed/36798690
http://dx.doi.org/10.3389/fonc.2022.1028825

Ejemplares similares